SECURITIES AND EXCHANGE COMMISSION
                             Washington, D. C. 20549

                                    FORM 10-Q

                 QUARTERLY REPORT UNDER SECTION 13 OR 15 (d) OF
                       THE SECURITIES EXCHANGE ACT OF 1934



For Quarter Ended                                    February 3, 1996

Commission File Number                                    1-10512


                          Del Global Technologies Corp.

             (Exact name of registrant as specified in its charter)

          New York                                       13-1784308
(State or other jurisdiction of             (I.R.S. Employer Identification No.)
 incorporation or organization)

                      One Commerce Park, Valhalla, NY 10595

                    (Address of principal executive offices)
                                   (Zip Code)

                                 (914) 686-3600

               (Registrant's telephone number including area code)

                              Del Electronics Corp.

(Former  name,  former  address and former  fiscal year,  if changed  since last
report)

Indicate by check mark whether the registrant (1) has filed all reports required
to be filed  by  Section  13 or 15 (d) of the  Securities  Exchange  Act of 1934
during the preceding 12 months (or for such shorter  period that the  registrant
was  required  to file such  reports),  and (2) has been  subject to such filing
requirements for the past 90 days.

Yes      X                 No

Indicate the number of shares  outstanding  of each of the  issuer's  classes of
common stock, as of the close of the period covered by this report.

                         Common Stock - 4,288,758 shares


<PAGE>













                                     PART I


Item 1.           Financial Statements

                  Consolidated  Balance  Sheets - February  3, 1996 and July 29,
                  1995.

                  Consolidated Statements of Income for the Three Months and Six
                  Months ended February 3, 1996 and January 28, 1995.

                  Consolidated Statements of Cash Flows for the Six Months ended
                  February 3, 1996 and January 28, 1995.

                  Notes to Consolidated Financial Statements



























                                        1

<PAGE>
                  DEL GLOBAL TECHNOLOGIES CORP. & SUBSIDIARIES
                           CONSOLIDATED BALANCE SHEETS
                                  (Unaudited)
<TABLE>
<CAPTION>
                                     ASSETS
                                                        February 3,     July 29,
                                                           1996           1995
                                                           ----           ----
<S>                                                    <C>           <C>
CURRENT ASSETS
        Cash and cash equivalents ..................   $   162,052   $   505,989
        Investments available-for-sale .............       497,790       378,534
        Trade receivables ..........................     5,725,121     6,456,853
        Cost and estimated earnings in excess of
           billings on uncompleted contracts .......       404,030       395,847
        Inventory ..................................    19,908,557    18,038,358
        Prepaid expenses and other current assets ..     1,567,122     1,117,963
                                                         ---------     ---------
           Total current assets ....................    28,264,672    26,893,544
                                                        ----------    ----------

FIXED ASSETS - NET .................................     8,175,092     7,752,781
GOODWILL - NET .....................................     2,802,018     2,865,408
DEFERRED CHARGES ...................................       801,665       876,638
OTHER ASSETS .......................................       626,212       666,263
                                                           -------       -------
        TOTAL ......................................   $40,669,659   $39,054,634
                                                       ===========   ===========

                      LIABILITIES AND SHAREHOLDERS' EQUITY

CURRENT LIABILITIES
        Current portion of long-term debt ..........   $   943,383   $   943,383
        Accounts payable - trade ...................     2,748,117     2,539,615
        Accrued liabilities ........................     2,137,886     2,484,435
        Income taxes payable .......................       544,598       277,830
                                                           -------       -------
           Total current liabilities ...............     6,373,984     6,245,263
                                                         ---------     ---------

LONG-TERM LIABILITIES
        Long-term debt (less current portion above)     11,755,397    11,902,951
                                                                             
        Other ......................................       782,424       775,541
        Deferred taxes payable .....................       605,806       605,806
                                                           -------       -------
           Total liabilities .......................    19,517,611    19,529,561
                                                        ----------    ----------
SHAREHOLDERS' EQUITY
        Common stock, $.10 par value
           Authorized - 10,000,000 shares
           Issued and outstanding -
           February 3, 1996 - 4,346,983
           July 29, 1995 - 4,253,486 ...............       434,698       412,960
        Additional paid-in capital .................    17,490,139    16,239,784
        Retained earnings ..........................     3,563,896     3,189,244
                                                         ---------     ---------
                                                        21,488,733    19,841,988
                                                        ----------    ----------
        Less common shares in treasury - 
        February 3, 1996 - 58,225,
        July 29, 1995 - 55,165 .....................       336,685       316,915
                                                           -------       -------
        Total shareholders' equity .................    21,152,048    19,525,073
                                                        ----------    ----------
           TOTAL ...................................   $40,669,659   $39,054,634
                                                       ===========   ===========
</TABLE>
See notes to consolidated financial statements
                                       2
<PAGE>
                  DEL GLOBAL TECHNOLOGIES CORP. & SUBSIDIARIES
                        CONSOLIDATED STATEMENTS OF INCOME
                                   (Unaudited)
<TABLE>
<CAPTION>
                                                                               Three Months Ended           Six Months Ended    
                                                                               ------------------           ----------------
                                                                              Feb. 3,       Jan 28,       Feb. 3,       Jan 28,
                                                                               1996          1995          1996          1995
                                                                               ----          ----          ----          ----
<S>                                                                        <C>           <C>           <C>           <C>
Net Sales ..............................................................   $ 9,329,438   $ 7,579,366   $16,800,619   $13,715,422

Costs and expenses:
    Cost of sales ......................................................     5,553,918     4,280,738     9,744,552     7,499,943
    Research and development ...........................................       789,063       688,294     1,431,894     1,209,050
    Selling, general & administrative ..................................     1,784,151     1,578,032     3,356,117     3,054,806
    Interest expense - net .............................................       285,984       305,287       595,211       576,293
                                                                               -------       -------       -------       -------
                
                                                                             8,413,116     6,852,351    15,127,774    12,340,092
                                                                             ---------     ---------    ----------    ----------
    Income before provision
    for income taxes ...................................................       916,322       727,015     1,672,845     1,375,330

Provision for income taxes: ............................................       283,261       221,800       510,218       419,500
                                                                               -------       -------       -------       -------

    Net income .........................................................   $   633,061   $   505,215   $ 1,162,627   $   955,830
                                                                           ===========   ===========   ===========   ===========

Per share amounts:
    Net income per common share
    and common share equivalents,
    primary and fully diluted ..........................................   $       .12   $       .10   $       .23   $       .19
                                                                           ===========   ===========   ===========   ===========

Weighted average number of
    common shares outstanding
    and common share equivalents .......................................     5,276,094     4,911,717     5,252,173     5,012,086
                                                                             =========     =========     =========     =========
</TABLE>



See notes to consolidated financial statements






                                        3

<PAGE>
                  DEL GLOBAL TECHNOLOGIES CORP. & SUBSIDIARIES
                      CONSOLIDATED STATEMENTS OF CASH FLOWS
                                   (Unaudited)

<TABLE>
<CAPTION>

                                                           Six Months Ended
                                                           ----------------
                                                         Feb. 3,       Jan. 28,
                                                          1996           1995
                                                          ----           ----
<S>                                                    <C>            <C>           
CASH FLOWS FROM OPERATING ACTIVITIES:
     Net income .......................................$1,162,627     $ 955,830
     Adjustments to reconcile net income to net 
         cash provided by (used in) operating
         activities:
         Imputed interest .............................     33,133       18,991
         Depreciation .................................    338,919      388,492
         Amortization .................................    194,617      202,500
     Changes in assets and liabilities:
         Decrease in trade receivables ................    731,732      946,817
         (Increase) decrease in cost and estimated
                  earnings in excess of billings
                  on  uncompleted contracts ...........     (8,183)     168,445
         Increase in inventory ........................ (1,870,199)  (2,047,079)
         Increase in prepaid and other current
                  assets ..............................    (503,223)   (196,453)
         Decrease (increase) in other assets ..........      37,861     (16,692)
         Increase (decrease) in accounts payable -
                  trade ...............................     208,502    (686,763)
         (Decrease) increase in accrued liabilities ...    (346,549)     12,804
         Increase in income taxes payable .............     266,768      96,162
                                                            -------      ------
                  Net cash provided by (used in) 
                  operating activities ................     246,005    (156,946)
                                                            -------    -------- 

CASH FLOWS FROM INVESTING ACTIVITIES:
         Expenditures for fixed assets ................    (761,231)   (429,508)
         (Investment in) sale of marketable
                  securities - net ....................    (119,256)     52,731
         Payments to former shareholders of
                  subsidiary acquired .................     (26,250)   (195,375)
                                                            -------    -------- 
         Net cash used in investing activities ........    (906,737)   (572,152)
                                                           --------    -------- 

CASH FLOWS FROM FINANCING ACTIVITIES:
         Net (repayment of) proceeds from 
                  bank borrowing ..........................(147,554)    578,105
         Payment for repurchase of shares ................. (19,770)   (122,554)
         Proceeds from exercise of stock options
                  & warrants .............................. 491,867      62,446
         Other ............................................  (7,748)    (18,935)
                                                             ------     ------- 
               Net cash provided by financing activities    316,795     499,062
                                                            -------     -------
                                                                     (continued)      
</TABLE>
See notes to consolidated financial statements
                                        4

<PAGE>    
                  DEL GLOBAL TECHNOLOGIES CORP. & SUBSIDIARIES
                      CONSOLIDATED STATEMENTS OF CASH FLOWS
                                   (Unaudited)

<TABLE>
<CAPTION>
                                                         Six Months Ended
                                                         ----------------
                                                      Feb. 3,          Jan. 28,
                                                       1996              1995
                                                       ----              ----
<S>                                                 <C>               <C> 
NET DECREASE IN CASH AND CASH EQUIVALENTS ........  $(343,937)        $(230,036)

CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD ...    505,989           445,597
                                                      -------           -------

CASH AND CASH EQUIVALENTS, END OF PERIOD .........  $ 162,052         $ 215,561
                                                    =========         =========


SUPPLEMENTAL DISCLOSURES OF CASH FLOW
         INFORMATION:
         
         Interest paid ...........................  $ 569,505         $ 432,586
                                                    ---------         ---------

         Incomes taxes paid ......................  $ 269,405        $   98,930
                                                    ---------        ----------
</TABLE>








                                                                  
                                                                (concluded)


See notes to  consolidated financial statements


                                                                 


                                        5

<PAGE>

                                       
                  DEL GLOBAL TECHNOLOGIES CORP. & SUBSIDIARIES
                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                                   (Unaudited)



NOTE 1    In the opinion of the Company, the accompanying unaudited consolidated
          financial  statements  contain  all  adjustments  (consisting  of only
          normal recurring  adjustments) necessary to present fairly the results
          of the Company's financial position as of February 3, 1996 and January
          28, 1995 and the results of its  operations and its cash flows for the
          six months ended February 3, 1996 and January 28, 1995. The accounting
          policies  followed  by the  Company  are  set  forth  in Note 1 to the
          Company's  consolidated  financial statements as of July 29, 1995. The
          consolidated  financial  statements should be read in conjunction with
          the  notes to the  consolidated  financial  statements  as of July 29,
          1995.

NOTE 2    The results of  operations  for the three and six month  periods ended
          February 3, 1996 are not  necessarily  indicative of the results to be
          expected for the full year.

NOTE 3    PERCENTAGE OF COMPLETION ACCOUNTING
<TABLE>
<CAPTION>

                                                                Balance at
                                                             February 3, 1996
                                                             ----------------
              <S>                                                <C>  
              Costs incurred on uncompleted contracts ........   $344,309

              Estimated earnings .............................     94,921
                                                                   ------
                                                                  439,230

              Less:  Billings to-date ........................     35,200
                                                                   ------
              Costs and estimated earnings in excess
                     of billings on uncompleted
                     contracts ...............................   $404,030
                                                                 ========
</TABLE>
          The  backlog of  unshipped  contracts  being  accounted  for under the
          percentage of completion method of accounting was $625,570 at February
          3, 1996.
                                       6
<PAGE>
NOTE 4    Inventory  is  stated  at a lower  of cost  (first-in,  first-out)  or
          market.  Inventories  and their effect on cost of sales are determined
          by physical count for annual  reporting  purposes and are estimated by
          management for interim  reporting  purposes  based on estimated  gross
          margins.
<TABLE>
<CAPTION>
          Inventory consists of the following:
                                                   February 3,        July 29,     
                                                      1996              1995
                                                      ----              ----
          <S>                                     <C>               <C>          
          Finished goods .......................  $ 4,853,706       $ 4,398,096
          Work in process ......................    8,434,964         7,642,588
          Raw material and purchased parts .....    6,619,887         5,997,674
                                                    ---------         ---------
                 Total                            $19,908,557       $18,038,358
                                                  ===========       ===========
</TABLE>

NOTE 5    FIXED ASSETS
<TABLE>
<CAPTION>
          Fixed assets consist of the following:
                                                        February 3,     July 29,
                                                           1996           1995
                                                           ----           ----
      <S>                                              <C>           <C>
          Land .....................................   $   694,046   $   694,046
          Building .................................     2,146,025     2,146,025
          Machinery and equipment ..................     7,164,933     6,624,296
          Furniture and fixtures ...................       802,924       773,694
          Leasehold improvements ...................       795,755       790,226
          Construction in progress .................       210,435        76,023
          Transportation equipment .................        11,425        10,987
                                                            ------        ------
                                                        11,825,543    11,115,297
          Less accumulated depreciation and
                amortization .......................     3,650,451     3,362,516
                                                         ---------     ---------
                                                       $ 8,175,092   $ 7,752,781
                                                       ===========   ===========
</TABLE>

                  Construction in progress relates to computer equipment and the
                  computerization of certain of the Company's  manufacturing and
                  accounting systems.

NOTE 6    Net income per common share was computed  using the modified  treasury
          stock method.  This method was utilized  since the number of shares of
          common  stock  obtainable  upon the assumed  exercise  of  outstanding
          options  and  warrants  in the  aggregate  exceeded  20 percent of the
          number of common  shares  outstanding  at the end of the  period.  The
          weighted average number of common shares and common share  equivalents
          for the period and for all periods  presented  includes  the effect of
          the 3 percent stock  dividend  declared on November 20, 1995 (see Note
          7).
                                        7
 <PAGE>

NOTE 7    On November 20, 1995, the Company  declared a 3 percent stock dividend
          to holders of record on December  5, 1995,  which was paid on December
          21, 1995.

NOTE 8    LONG-TERM  DEBT AND  ACQUISITION 
          
          On March 5, 1996 the  Company  and its lending  bank  entered  into an
          Amended and Restated Credit  Agreement  wherein the bank increased the
          Company's line of credit to  $24,000,000,  consisting of a $10,000,000
          five-year  term  loan  and  a  four-year   revolving  credit  line  of
          $14,000,000.  Initial  borrowings made under this credit line on March
          6,  1996  were  used to pay off  existing  term  loans,  the  existing
          revolving  credit loan balance and to fund the  acquisition of certain
          assets  of  the  GENDEX  Medical   Division   ("GENDEX")  of  Dentsply
          International  Inc. Borrowing under the revolving credit loan is based
          upon a formula based on 80 percent of eligible accounts receivable and
          50  percent of  inventory,  with a  $2,000,000  maximum  sublimit  for
          letters of  credit.  Interest  will be  computed  at prime,  or at the
          Company's  option,  at a rate tied to the London  Interbank  Borrowing
          Rate  ("LIBOR"). 

          On  March 6,  1996,  the  Company  and its  newly-formed  wholly-owned
          subsidiary,  GENDEX-DEL Medical Imaging Corp. acquired certain assets,
          including  inventories,  fixed assets,  intangibles and the use of the
          GENDEX  trade  name,  of  the  GENDEX  Medical  Division  of  Dentsply
          International Inc. for $5,700,000 in cash and a subordinated term note
          of  $1,800,000.  The  subordinated  term note bears  interest  at 7.75
          percent, which is payable quarterly, with principal payments beginning
          three  years  after  closing.  The  Company  assumed the lease for the
          GENDEX  facility  in  Franklin  Park,  Illinois  and will  operate the
          business under the GENDEX-DEL  name. The Company entered into a supply
          agreement with Dentsply  International Inc. for certain components and
          parts used in the  manufacture of medical x-ray  equipment and systems
          of GENDEX.













                                        8

<PAGE>
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
AND RESULTS OF OPERATIONS


LIQUIDITY AND CAPITAL RESOURCES

         The  Company  had a line  of  credit  of  $10,000,000  with  $8,225,000
outstanding  and  outstanding  balances  on  two  term  loans  of  approximately
$1,821,000  and  $2,625,000  on  February 3, 1996.  Borrowing  under the line of
credit were based on 85 percent of eligible  accounts  receivable and 50 percent
of inventory, with a $1,000,000 maximum sub-limit for letters of credit.

         On March 5, 1996,  the  Company and its lending  bank  entered  into an
Amended and Restated Credit  Agreement  wherein the bank increased the Company's
line of credit to $24,000,000,  consisting of a five-year  $10,000,000 term loan
and a four-year  revolving line of credit of $14,000,000.  Borrowings  under the
revolving line of credit are based on 80 percent of eligible accounts receivable
and 50 percent of inventory,  with a $2,000,000 maximum sub-limit for letters of
credit. Borrowings under this credit line were used to pay off the existing term
loans and the existing revolving credit loan balance.  Interest will be computed
at prime,  or at the Company's  option,  at a rate tied to LIBOR.  Approximately
$5,700,000 of this credit line was used to purchase certain assets of the GENDEX
Medical  Division  from  Dentsply  International  Inc.,  on  March 6,  1996.  In
connection  with such purchase,  the Company  delivered a seven-year  $1,800,000
subordinated note to Dentsply with interest at 7.75 percent,  payable quarterly.
After the  acquisition,  the Company had  outstanding  borrowings of $10,000,000
under the term loan and $8,300,000  under the revolving  credit loan. The unused
and available portion of the line of credit was approximately $3,243,000,  after
deducting outstanding letters of credit of approximately $652,000.

         The Company believes its current financial resources,  future operating
revenue and existing  credit lines will be  sufficient  to meet its  foreseeable
working capital requirements.

         Working  capital  was  approximately  $21,891,000  at February 3, 1996,
compared  to  approximately  $20,648,000  at July 29,  1995,  an increase of 6.0
percent.  The current ratio increased to 4.43 to 1 at February 3, 1996 from 4.31
to 1 at July 29, 1995.

         Investments available-for-sale of approximately $498,000 at February 3,
1996  consist  primarily  of  corporate  debt  securities  and  equities.  These
investments  are used to fund a  deferred  compensation  plan for a key  Company
employee.

         Trade receivables at February 3, 1996 decreased  approximately $732,000
as compared to July 29, 1995 as the result of collections and lower sales levels
in the quarter ended  February 3, 1996 as compared to the quarter ended July 29,
1995. This is primarily attributable to more workdays in the last quarter of the
Company's  fiscal year as compared to the second  quarter of its fiscal year due
to plant shutdowns for the calendar year end holidays.

                                        9

<PAGE>
         Unbilled contract revenues were  approximately  $404,000 at February 3,
1996 as compared to $396,000 at July 29, 1995 due to work performed on contracts
which utilize the percentage of completion method of accounting.

         Inventory at February 3, 1996  increased  approximately  $1,870,000  as
compared to July 29,  1995.  Major new orders  received in the six months  ended
February 3, 1996 resulted in the increase of inventory levels.


         Prepaid  expenses  and other  current  assets  increased  approximately
$503,000 at February 3, 1996 as compared to July 29,  1995.  This  increase  was
primarily  attributable  to  advanced  payments  for  inventory  for Del Medical
Systems under its exclusive  distribution agreement for diagnostic medical image
enhancers,  worker's  compensation  insurance policy premiums and costs incurred
relating to the acquisition of certain assets of the GENDEX Medical  Division of
Dentsply International Inc.

         Capital  expenditures  for the six months  ended  February 3, 1996 were
approximately $761,000.  These expenditures were primarily for assembly and test
equipment  for improved  manufacturing  efficiencies.  Depreciation  expense was
approximately  $339,000 for the six months ended February 3, 1996 as compared to
approximately  $388,000  for the six months  ended  January  28,  1995,  because
certain  classes  of fixed  assets  have been fully  depreciated.  There were no
material open  commitments  for capital  equipment  expenditures  at February 3,
1996.  The  funds  for  capital  expenditure   improvements  were  derived  from
operations and short-term borrowing.

         The   Company's   long-term   debt  at  February   3,  1996   decreased
approximately  $148,000  as  compared  to July 29,  1995.  The  decrease  is due
primarily to collections of trade receivables during the period.

RESULTS OF OPERATIONS

          Net  sales  for  the  three  months   ended   February  3,  1996  were
approximately  $9,329,000 compared to approximately  $7,579,000,  an increase of
approximately 23.1 percent over the corresponding  period in the prior year. Net
sales for the six months ended February 3, 1996 were  approximately  $16,801,000
compared to approximately $13,715,000, an increase of approximately 22.5 percent
over the  corresponding  period in the prior year.  These  increases were due to
higher  sales  levels of  products  supplied  by the  Company  to its  customers
manufacturing end-user medical diagnostic and industrial products.

         Cost of sales,  as a percentage of net sales for the three months ended
February  3, 1996,  was 59.5  percent  compared  to 56.5  percent  for the prior
corresponding  period.  Cost of sales,  as a percentage of net sales for the six
months ended February 3, 1996, was 58.0 percent compared to 54.7 percent for the
prior corresponding  period. These changes were due to the change in product mix
in the periods.

         Research and development  expenses increased to approximately  $789,000
for the three months ended February 3, 1996 from approximately  $688,000 for the
three months ended January 28, 1995. Research and development expenses increased
to  approximately  $1,432,000  for the six months  ended  February  3, 1996 from
approximately  $1,209,000 for the six months ended January 28, 1995. The Company
continues  to invest in  research  and  development  in order to  introduce  new
state-of-the-art products for its medical and industrial markets.


                                       10

<PAGE>

          Selling,   general  and  administrative  expenses  were  approximately
$1,784,000  in  the  three  months  ended   February  3,  1996  as  compared  to
approximately $1,578,000 in the same period in the prior year. Selling, general,
and administrative  expenses  increased to approximately  $3,356,000 for the six
months ended February 3, 1996 from approximately  $3,055,000 for the same period
in the prior year.  These  increases  were primarily  attributable  to increased
selling  expenses,  advertising and commissions due to increased sales levels in
the respective periods.

         Net interest  expense was  approximately  $286,000 for the three months
ended February 3, 1996 compared to approximately  $305,000 for the corresponding
prior period.  This  decrease was  attributable  to lower  interest  rates.  Net
interest expense was approximately $595,000 for the six months ended February 3,
1996 compared to approximately $576,000 for the corresponding prior period. This
increase is due to higher average credit balances  outstanding in the six months
ended February 3, 1996, partly offset by lower interest rates.

         Income tax expense was 30.5 percent of pre-tax income in the six months
ended  February 3, 1996 and the six months ended January 28, 1995.  The decrease
from statuatory rates is primarily due to sales being made through the Company's
Foreign Sales Corporation, research and development and other tax credits.

         Net income  increased  to  approximately  $633,000 for the three months
ended February 3, 1996, an increase of approximately  25.3 percent from $505,000
for the prior  corresponding  period.  Net income per common share  increased to
$.12 from $.10 even though the weighted number of common shares  outstanding and
common share equivalents  increased  approximately 7.4 percent to 5,276,094 from
4,911,717.  Net income increased to approximately  $1,163,000 for the six months
ended  February  3,  1996,  an  increase  of  approximately  21.6  percent  from
approximately  $956,000 for the prior  corresponding  period. For the six months
ended  February 3, 1996 primary and fully  diluted net income per share was $.23
as compared to $.19 for the six months  ended  January 28,  1995.  the number of
outstanding  shares and common share equivalents  increased 4.8 percent from the
six month period ended  January 28,  1995.  The  increases in net income for the
three and six months are  primarily  due to higher sales levels to its customers
manufacturing end-user medical diagnostic and industrial products.

          The backlog of unshipped orders at February 3, 1996 was  approximately
$21.0 million.
















                                       11

<PAGE>

                                     PART II

Item 1.           Legal Proceedings  - None


Item 2.           Changes in Securities  - None


Item 3.           Defaults on Senior Securities - None


Item 4.           Submission to a Vote of Security Holders

                  At the annual meeting of  stockholders  of the Company held on
                  February 14, 1996, the stockholders:

                  (a)      Elected  the  following directors:  Natan V. Bertman,
                           Raymond Kaufman, David  Michael, Seymour Rubin, James
                           Tiernan, Leonard A. Trugman.
<TABLE>
<CAPTION>

           Election of Directors
           ---------------------
                                                              For       Withheld
                                                              ---       --------
           <S>                                             <C>            <C>
           L.A. Trugman ................................   3,698,097      59,332
           N.V. Bertman ................................   3,703,838      53,591
           R. Kaufman ..................................   3,703,246      54,183
           D. Michael ..................................   3,715,254      42,175
           S. Rubin ....................................   3,704,382      53,047
           J. Tiernan ..................................   3,699,274      58,155
</TABLE>
                  (b)      Approved  the  Company's name  change  to Del Global 
                           Technologies Corp.

                              For             Against           Abstain
                              ---             -------           -------
                           3,697,546          43,679            16,204

                  (c)      Approved   the   proposal  to  amend  the   Company's
                           Non-qualified   Stock  Option  Plan  to  increase  by
                           250,000 the number of shares of common stock reserved
                           for issuance thereunder.

                              For        Against      Abstain     Broker No Vote
                              ---        -------      -------     --------------
                           2,089,426     313,647       57,347       1,297,009

         Item 5.           Other Information

                  (a)      Exhibits:
                             
                           Exhibit 11 - Computation of Earnings per Common Share
                           Exhibit 27 - Financial Data Schedule

                  (b)      Report on Form 8-K:

                           As filed with Commission on March 21, 1996.


                                       12

<PAGE>

                                   SIGNATURES


Pursuant to the  requirements  of the  Securities  and Exchange Act of 1934, the
Registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned thereunto duly authorized.






                                         DEL GLOBAL TECHNOLOGIES CORP.



                                         /S/LEONARD A. TRUGMAN
                                         ---------------------
                                         Leonard A. Trugman
                                         Chairman of the Board,
                                         Chief Executive Officer
                                         and President




                                         /S/MICHAEL H. TABER
                                         -------------------
                                         Michael H. Taber
                                         Vice President Finance and Secretary
                                         Chief Accounting Officer




Dated:   March 22, 1996





                                       13